Management of Testicular Germ Cell Tumours
Author Information
Author(s): V. Raina, N.K. Shukla, G.K. Rath, N.P. Gupta, M.C. Mishra, T.K. Chaterjee, A.K. Kripalani
Primary Institution: Institute Rotary Cancer Hospital, All India Institute of Medical Sciences
Hypothesis
What are the clinical profiles and management challenges of germ cell tumours of the testis in India?
Conclusion
The study highlights the need for improved detection and treatment strategies for testicular cancer in India, as many patients are unable to complete their treatment due to financial constraints.
Supporting Evidence
- 68.5% of patients completed their prescribed treatment.
- The probability of survival for those who completed treatment was 0.77 at 4 years.
- Testicular tumours account for only about 1% of all cancers but are the most common neoplasms in the 15-35 year old age group.
- Almost half of the patients presented in advanced stages (stages IIc-IV).
- Patients with undescended testis formed an important subgroup accounting for 14% of cases.
Takeaway
This study looked at 108 men with testicular cancer and found that many couldn't finish their treatment because it was too expensive, even though this type of cancer can often be cured.
Methodology
A retrospective analysis of case records of patients with testicular tumours registered at the hospital from 1985 to 1990.
Potential Biases
Potential bias due to socioeconomic factors affecting treatment completion.
Limitations
High dropout rates of patients who did not complete treatment and lack of follow-up data for some patients.
Participant Demographics
Patients primarily from low socioeconomic backgrounds, with a median age of 35 for seminomas and 30 for non-seminomatous germ cell tumours.
Want to read the original?
Access the complete publication on the publisher's website